Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time? | Front Immunol | 2023 | 37143664 | PubTator, text mining | PubMed |
| Macrophage-derived exosome promotes regulatory T cell differentiation in malignant pleural effusion. | Front Immunol | 2023 | 37143656 | PubTator, text mining | PubMed |
| Identification and validation of immunogenic cell death-related score in uveal melanoma to improve prediction of prognosis and response to immunotherapy. | Aging (Albany NY) | 2023 | 37142279 | PubTator, text mining | PubMed |
| Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives. | Acta Pharm Sin B | 2023 | 37139405 | PubTator, text mining | PubMed |
| LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signaling. | Front Immunol | 2023 | 37138866 | PubTator, text mining | PubMed |
| Inflammation and endothelial function-related gene polymorphisms are associated with carotid atherosclerosis-A study of community population in Southwest China. | Brain Behav | 2023 | 37137812 | PubTator, text mining | PubMed |
| Comprehensive analysis of prognostic value and immunotherapy prospect of brain cytoplasmic RNA1 in hepatocellular carcinoma. | World J Gastrointest Oncol | 2023 | 37123057 | PubTator, text mining | PubMed |
| IL-17 cytokines preferentially act on naïve CD4+ T cells with the IL-17AF heterodimer inducing the greatest functional changes. | PLoS One | 2023 | 37115755 | PubTator, text mining | PubMed |
| Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity. | J Immunol Res | 2023 | 37114204 | PubTator, text mining | PubMed |
| Combination Therapy of Radiation and Hyperthermia, Focusing on the Synergistic Anti-Cancer Effects and Research Trends. | Antioxidants (Basel) | 2023 | 37107299 | PubTator, text mining | PubMed |
| Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC. | PLoS Biol | 2023 | 37104245 | PubTator, text mining | PubMed |
| mRNA vaccination in breast cancer: current progress and future direction. | J Cancer Res Clin Oncol | 2023 | 37100972 | PubTator, text mining | PubMed |
| Harnessing novel strategies and cell types to overcome immune tolerance during adoptive cell therapy in cancer. | J Immunother Cancer | 2023 | 37100458 | PubTator, text mining | PubMed |
| Intracellular Adhesion Molecule-1 Improves Responsiveness to Immune Checkpoint Inhibitor by Activating CD8+ T Cells. | Adv Sci (Weinh) | 2023 | 37097643 | PubTator, text mining | PubMed |
| Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity. | Front Immunol | 2023 | 37063898 | PubTator, text mining | PubMed |
| Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation. | Front Immunol | 2023 | 37056774 | PubTator, text mining | PubMed |
| Modulation of Dietary Fatty Acids in an Open-Label Study Improves Psoriasis and Dampens the Inflammatory Activation Status. | Nutrients | 2023 | 37049538 | PubTator, text mining | PubMed |
| The Role of Cytokines in Cholesterol Accumulation in Cells and Atherosclerosis Progression. | Int J Mol Sci | 2023 | 37047399 | PubTator, text mining | PubMed |
| Oncolytic Adenoviruses Armed with Co-Stimulatory Molecules for Cancer Treatment. | Cancers (Basel) | 2023 | 37046608 | PubTator, text mining | PubMed |
| Development of an antibody-ligand fusion protein scFvCD16A-sc4-1BBL in Komagataella phaffii with stimulatory activity for Natural Killer cells. | Microb Cell Fact | 2023 | 37041591 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=25